Zusammenfassung
Die aktuelle Leitlinie der ESC stellt ein hilfreiches und im klinischen Alltag praktikables Instrument in der Risikostratifizierung von Patienten im Kontext eines geplanten operativen Eingriffes als auch im perioperativen Management dar. Besonders wertvoll erscheinen die klare Strukturierung der Risikostratifizierung von Patienten und geplantem operativem Eingriff in den 3 Risikokategorien niedrig, mittel und hoch und die sich daraus ableitenden Konsequenzen im medikamentösen als auch diagnostischen und interventionellen prä-, peri- und postoperativen Management. Der grundlegende Algorithmus und Entscheidungsbaum wird auch in den parallel zu diesem Kommentar publizierten Pocket-Leitlinien der Deutschen Gesellschaft für Kardiologie eine zentrale Stellung einnehmen.
Abstract
The current ESC guideline is a useful tool in clinical practice for cardiac risk stratification of patients in the context of surgical procedures as well as for perioperative management. The straight algorithm stratifies patients and surgical procedures into three categories: low, intermediate, and high risk. This results in an individualized medical therapy as well as diagnostic and interventional pre-, peri- and postoperative management. In parallel, the underlying algorithm will be published in the Pocket-Leitlinien of the German Society of Cardiology.
Literatur
http://www.prismant.nl/. Ziekenhuisstatistiek – Verrichtingen. 2008, Prismant
Lee TH, Marcantonio ER, Mangione CM et al (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043–1049
Boersma E, Kertai MD, Schouten O et al (2005) Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 118:1134–1141
Poldermans D, Bax JJ, Kertai MD et al (2003) Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107:1848–1851
Poldermans D, Bax JJ, Schouten O et al (2006) Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol 48:964–969
Poldermans D, Boersma E, Bax JJ et al (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341:1789–1794
Devereaux PJ, Yang H, Yusuf S et al (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371:1839–1847
Naughton C, Feneck RO (2007) The impact of age on 6-month survival in patients with cardiovascular risk factors undergoing elective non-cardiac surgery. Int J Clin Pract 61:768–776
Monaco M, Stassano P, Di Tommaso L et al (2009) Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. J Am Coll Cardiol 54(11):989–996
Brady AR, Gibbs JS, Greenhalgh RM et al (2005) Perioperative betablockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41:602–609
Juul AB, Wetterslev J, Gluud C et al (2006) Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 332:1482
Mangano DT, Layug EL, Wallace A, Tateo I (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335:1713–1720
Yang H, Raymer K, Butler R et al (2006) The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152:983–990
Zaugg M, Bestmann L, Wacker J et al (2007) Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 107:33–44
Beattie WS, Wijeysundera DN, Karkouti K et al (2008) Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 106:1039–1048
Hindler K, Shaw AD, Samuels J et al (2006) Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 105:1260–1272; quiz 1289–1290
Williams TM, Harken AH (2008) Statins for surgical patients. Ann Surg 247:30–37
Schouten O, Hoeks SE, Welten GM et al (2007) Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol 100:316–320
Sun YP, Zhu BQ, Browne AE et al (2001) Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function. J Cardiovasc Pharmacol Ther 6:175–181
Burger W, Chemnitius JM, Kneissl GD, Rucker G (2005) Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J Intern Med 257:399–414
Biondi-Zoccai GG, Lotrionte M, Agostoni P et al (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27:2667–2674
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kelm, M., Osterhues, H., Hennerici, M. et al. Kommentar zu den „ESC Guidelines for Pre-Operative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery“. Kardiologe 4, 375–382 (2010). https://doi.org/10.1007/s12181-010-0293-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12181-010-0293-z
Schlüsselwörter
- Risikostratifizierung
- Perioperatives Management
- Nichtkardiale Chirurgie
- Thrombozytenaggregationshemmung
- Antikoagulation